Pfizer Announces Positive Top-Line Results Of Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*

Data to Be Presented at 9th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) on March 12, 2014 

Monday, February 24, 2014 - 02:00am
Media Contact:
Sally Beatty
(212) 733-6566 
Investor Contact:
Chuck Triano 
(212) 733-3901